Galangal for Inflammation and Joint Pain
This is the strongest laboratory story galangal has, and the clearest example on this site of how far a strong laboratory story can be from a useful clinical one.
The molecule at the centre of it is 1'-acetoxychavicol acetate, usually abbreviated ACA and sometimes written galangal acetate, and it comes specifically from greater galangal, Alpinia galanga — the pale Thai and Indonesian cooking rhizome. ACA suppresses NF-κB, the master switch of inflammatory gene expression, and it has done so reproducibly in independent laboratories since 1998. In the natural-products literature that counts as unusually solid. And yet, after nearly three decades, no randomised controlled trial has tested ACA, or galangal on its own, against any inflammatory condition in a human being — not osteoarthritis, not rheumatoid arthritis, not inflammatory bowel disease, not anything. The one randomised trial that included galangal gave it combined with ginger: among 247 evaluable patients with knee osteoarthritis, 63% on the extract versus 50% on placebo had a reduction in knee pain on standing (P = 0.048).
Table of Contents
- The Claim, and the Short Answer
- What NF-κB Actually Is
- ACA: The Best-Replicated Finding
- Galangin and the Lesser Galangal Angle
- Animal Models of Inflammation
- The Thai Herbal Compress
- Why the Human Trial Is Missing
- What Has Been Tested for Joint Pain
- What the Evidence Adds Up To
- Cautions Specific to Anti-Inflammatory Use
- Key Research Papers
- Connections
- Featured Videos
The Claim, and the Short Answer
The claim is that galangal reduces inflammation and relieves arthritis and joint pain.
Short answer: the anti-inflammatory mechanism is well established at the level of preliminary (in-vitro) science and partially supported by preliminary (animal) work. The clinical benefit of galangal on its own in humans is untested — not disproved, not weakly supported, simply never studied alone. The one randomised trial that included it used a combined ginger and galangal extract in knee osteoarthritis (63% versus 50% responders on placebo, P = 0.048; see What Has Been Tested for Joint Pain), so galangal’s own share of that effect is unknown. Topical use in a multi-herb Thai compress has traditional use only status for galangal specifically, because the compress contains six or more plants and no trial has separated them.
Anyone telling you galangal "reduces inflammation" as though that were a settled clinical fact is describing cell-culture data in the language of medicine. The mechanism is real. The bridge to a person with a painful knee has not been built.
What NF-κB Actually Is
Almost every anti-inflammatory botanical claim eventually points at NF-κB, and the phrase gets used so loosely that it stops meaning anything. Here is what it is.
Picture a light switch mounted on the wall inside every immune cell, wired to about a hundred bulbs at once. Under normal conditions the switch is held down by a clamp — a protein called IκB, which physically grips NF-κB and keeps it out of the cell nucleus. When the cell detects a threat — bacterial lipopolysaccharide, a virus, tissue damage, a cytokine from a neighbouring cell — an enzyme complex tags the clamp for destruction. The clamp is shredded, NF-κB floats into the nucleus, and dozens of inflammatory genes switch on together: cyclooxygenase-2 (COX-2), inducible nitric oxide synthase, tumor necrosis factor-α, interleukin-1β, interleukin-6, and a long list of adhesion molecules that recruit more immune cells to the site.
That cascade is not a malfunction. It is how you clear an infection and heal a wound, and people born with defective versions of it die of infection young. Inflammation is not the enemy; unresolved inflammation is. The distinction matters for anyone considering a supplement described as "anti-inflammatory": what you want is better regulation, not blanket suppression, and a compound that shuts the switch down hard is not obviously a good thing to take every day for years.
Where NF-κB genuinely goes wrong is in conditions of persistent activation — the synovium of a rheumatoid joint, the wall of an inflamed bowel, the plaque in an artery. Those are the settings where a targeted inhibitor could be valuable, and they are exactly the settings where galangal has not been tested.
ACA: The Best-Replicated Finding
Evidence tier: preliminary (in vitro), but unusually well replicated.
The founding paper is Ohata and colleagues, "Inhibition by 1'-acetoxychavicol acetate of lipopolysaccharide- and interferon-gamma-induced nitric oxide production through suppression of inducible nitric oxide synthase gene expression in RAW264 cells," published in Carcinogenesis in 1998. In plain terms: they took a line of mouse macrophages, provoked them with bacterial toxin and an inflammatory cytokine, and showed that ACA prevented the cells from switching on the enzyme that manufactures nitric oxide during inflammation. The effect was at the level of gene expression — the enzyme was not being made, rather than being made and then blocked.
Murakami and colleagues extended this in the Journal of Nutrition in 2005 with a comparative study, "Zingiberaceous and citrus constituents, 1'-acetoxychavicol acetate, zerumbone, auraptene, and nobiletin, suppress lipopolysaccharide-induced cyclooxygenase-2 expression in RAW264.7 murine macrophages through different modes of action." Four food-derived molecules, all suppressing cyclooxygenase-2 induction, each by a somewhat different route. Cyclooxygenase-2 is the enzyme that ibuprofen and the coxib drugs inhibit, so this is the same target class as a familiar anti-inflammatory drug — approached from upstream, by preventing the enzyme being made at all rather than blocking it once present.
The work has continued. Kojima-Yuasa and Matsui-Yuasa's 2020 review in the Journal of Medicinal Food, "Pharmacological effects of 1'-acetoxychavicol acetate, a major constituent in the rhizomes of Alpinia galanga and Alpinia conchigera," is the best single entry point and catalogues anti-inflammatory, antimicrobial, antiallergic and antitumour activity across many cell systems.
Three caveats that decide how much this is worth.
Concentration. Cell-culture experiments apply purified compound directly to cells at micromolar concentrations. Whether eating galangal, or swallowing an extract, produces anything approaching those concentrations in a human joint is unknown, because the human pharmacokinetics of ACA have barely been characterised.
Stability. ACA is chemically unstable. It degrades with heat and on storage, which is why extract potency varies several-fold between products carrying identical labels — and why a compound that works beautifully in a freshly prepared solution may not survive a capsule, a stomach, and a liver.
Selectivity. A molecule that inhibits NF-κB inhibits it everywhere, including in the immune cells you need. Nobody has established what chronic NF-κB suppression by a dietary supplement does to infection risk over years, because nobody has run the study.
Galangin and the Lesser Galangal Angle
Evidence tier: preliminary (in vitro).
Galangin is a flavonol — 3,5,7-trihydroxyflavone — named after this plant genus, though it is more abundant in lesser galangal, Alpinia officinarum, and in bee propolis than in the culinary greater galangal most Western readers will buy. It is antioxidant in standard assays, inhibits several inflammatory mediators in cell culture, and has an enormous in-vitro literature summarised in Rampogu and colleagues' 2021 review in Biomedicine & Pharmacotherapy, "A comprehensive review on chemotherapeutic potential of galangin."
Two things follow from this that are easy to get wrong.
First, galangin research is mostly not greater-galangal research. If a product contains A. galanga and its marketing cites galangin studies, the citation belongs to a different species. If it contains A. officinarum and cites ACA studies, the same error runs the other way.
Second, galangin inhibits several cytochrome P450 drug-metabolising enzymes in vitro. That is a laboratory finding with no human confirmation, but it is the specific reason galangal's drug-interaction potential is taken seriously here rather than dismissed. Enzyme inhibition raises drug levels, and for medicines with a narrow therapeutic window, "slightly higher than intended" is the definition of a problem.
Animal Models of Inflammation
Evidence tier: preliminary (animal).
Between the dish and the person sits the rodent. Alpinia extracts have been run through the standard screening models — carrageenan-induced paw oedema, in which a locally injected irritant produces measurable swelling, and related acute inflammation and analgesia assays — and extracts generally reduce swelling relative to control. The A. officinarum gastroprotection work discussed on our digestive health page also points in an anti-inflammatory direction.
These models are useful and also famously permissive. Carrageenan paw oedema is an acute chemical irritation lasting hours; osteoarthritis is a chronic structural joint disease lasting decades, involving cartilage loss, subchondral bone change, and pain processing in the nervous system. A compound that reduces acute paw swelling in a rat has demonstrated that it is biologically active. It has not demonstrated that it will help a human knee.
There is also a publication-bias problem worth naming. Screening studies that find nothing are frequently never written up, so the published animal literature on any popular botanical is enriched for positive results. That is not a criticism of any individual paper; it is a reason not to count papers as though each were a vote.
The Thai Herbal Compress
Evidence tier: traditional use only for galangal specifically.
The most interesting real-world anti-inflammatory use of galangal is topical, not oral. In traditional Thai massage, a cloth-wrapped ball of herbs called luk pra kob is steamed and pressed against muscles and joints. The ball is a mixture — typically galangal alongside lemongrass, kaffir lime peel, turmeric, tamarind leaf, camphor and menthol-bearing plants — applied hot.
Clinical studies of Thai herbal compress therapy do exist, mostly small, mostly conducted in Thailand, in settings such as knee osteoarthritis and muscular neck and shoulder pain. Their results:
- Against ibuprofen. A 2014 randomised, evaluator-blind trial in 60 people with knee osteoarthritis compared one-hour sessions of Thai massage or Thai herbal compress (three times weekly) with oral ibuprofen (three times daily) for three weeks. All three provided “nearly comparable” clinical efficacy, with a trend toward the greatest improvement in the compress group.
- Pooled studies. A 2015 systematic review and meta-analysis of 13 studies involving 778 patients found that the overall effects of Thai herbal compress on osteoarthritis and muscle pain were not different from those of nonsteroidal anti-inflammatory drugs, knee exercise and hot compress.
- Added to massage. A 2020 randomised trial in 140 elderly people with chronic low back pain found no additional benefit from including a herbal compress in traditional Thai massage; both groups improved.
What they cannot tell you is whether galangal contributed anything. Three confounds are irreducible: the compress is a multi-herb mixture, the treatment includes heat, and it includes manual pressure applied by a practitioner. Heat alone reduces muscle pain. Massage alone reduces muscle pain. Attention and touch alone produce measurable improvement in pain scores. A trial that compares a herbal compress with no treatment cannot isolate the herbs. Comparisons with a plain hot compress are among the studies pooled in the 2015 meta-analysis, which found no difference in osteoarthritis and muscle pain, and adding a herbal compress to massage gave no extra benefit for low back pain.
None of this means the compress is useless. Steamed aromatic heat applied with skilled pressure is a genuinely pleasant and plausibly helpful thing for a stiff shoulder. It means the herbs, including galangal, are unproven components of an intervention that may work for other reasons.
Why the Human Trial Is Missing
It is worth understanding why a compound with thirty years of good mechanistic data — ACA — has never reached a clinical trial, because the reasons are structural rather than scientific. (Galangal itself reached one trial only as part of a combined ginger and galangal extract, in which 63% versus 50% of evaluable knee-osteoarthritis patients responded, P = 0.048; galangal on its own has not been tested.)
- Nobody can patent a spice. ACA is a natural product described in the open literature; there is no exclusivity to protect the cost of a trial, and a randomised trial in osteoarthritis with a meaningful sample size and duration is expensive.
- The chemistry is difficult. ACA's instability makes a standardised, shelf-stable investigational product genuinely hard to manufacture and to keep consistent across a multi-year study.
- The pharmacokinetics are unknown. You cannot rationally choose a dose without knowing absorption, distribution, metabolism and half-life in humans, and those studies have not been published.
- The supplement market does not require it. A product can be sold on the strength of cell-culture citations without any clinical evidence, so the commercial incentive to generate that evidence is close to zero.
The consequence for a reader is simple and slightly bleak: the absence of a trial of ACA, or of galangal on its own, is not evidence that galangal fails. It is evidence that nobody with money has had a reason to find out. The compound is genuinely promising and clinically unproven at the same time — those two states are compatible, and most of pharmacology lives in the gap between them.
What Has Been Tested for Joint Pain
If the reason you are reading this page is a painful joint, it is more useful to know what does have evidence.
- Exercise and load management. The single best-evidenced intervention for knee and hip osteoarthritis, ahead of any drug or supplement, and consistently recommended by major guidelines. It is also the one nobody sells.
- Boswellia. A botanical anti-inflammatory that was taken into randomised human osteoarthritis trials, with modest positive results. Whatever you think of the size of the effect, the trials exist.
- Turmeric and curcumin. The closest chemical relative of galangal with a real clinical literature in joint pain — and also a lesson in bioavailability, because unformulated curcumin is absorbed very poorly.
- Ginger. Randomised trials in knee osteoarthritis, with a small effect and gastrointestinal side effects at higher doses.
- Ginger combined with galangal. One randomised, double-blind, placebo-controlled trial did include galangal: 261 people with knee osteoarthritis took a standardized, highly concentrated extract of ginger and greater galangal (Alpinia galanga) or placebo twice daily for 6 weeks. Among the 247 evaluable patients, 63% on the extract versus 50% on placebo had a reduction in knee pain on standing of at least 15 mm on a visual analogue scale (P = 0.048). Gastrointestinal side effects, mostly mild, were more common on the extract (59 versus 21 patients). Galangal’s own share of the effect cannot be separated from ginger’s.
- Conventional treatment. Topical nonsteroidal anti-inflammatory drugs (NSAIDs), weight management where relevant, physiotherapy, and for inflammatory arthritis, disease-modifying drugs that prevent joint destruction. Rheumatoid arthritis in particular is a disease where delaying effective treatment causes permanent damage, and no botanical substitutes for that.
What the Evidence Adds Up To
Galangal as a cooking spice is delicious and safe in food quantities, and if the mechanistic work eventually translates, a spice-rich diet will have been slightly ahead of the evidence.
Galangal capsules sold for arthritis cite cell-culture papers; no dosing study exists for them, their dose cannot be based on human pharmacokinetics because none exist, their ACA content is unverifiable and possibly degraded, and joint pain has better-evidenced options. The botanicals that were taken into joint-pain trials (listed above) found effects of modest size.
Joint pain that is persistent, comes with morning stiffness lasting more than half an hour, involves swelling or redness, or affects many joints symmetrically points at inflammatory arthritis rather than wear-and-tear. In inflammatory arthritis, delaying effective treatment causes permanent joint damage, which no supplement prevents.
Cautions Specific to Anti-Inflammatory Use
- Bleeding risk. Several Zingiberaceae constituents affect platelet function in laboratory work. The concern applies to extract-strength galangal taken with warfarin, apixaban, rivaroxaban, clopidogrel or aspirin, and to the weeks before planned surgery.
- Drug metabolism. Galangin inhibits several cytochrome P450 enzymes in vitro. For narrow-therapeutic-index medications — warfarin, tacrolimus, some antiepileptics, some antiarrhythmics — no study has ruled an interaction out.
- Immune suppression is not a free lunch. "Anti-inflammatory" and "immune-supporting" are opposite directions, and marketing that claims both at once is not describing a coherent pharmacology. The question matters most for people who are immunosuppressed or on biologic therapy.
- Cancer treatment. ACA has a large anticancer cell-culture literature and is exactly the kind of compound that might interact with chemotherapy — and exactly the kind nobody has studied for that.
- Pregnancy, breastfeeding, and children. Food amounts are considered safe. No safety data exists for concentrated extracts or essential oil in these groups.
Key Research Papers
- Ohata T, Fukuda K, Murakami A, Ohigashi H, Sugimura T, Wakabayashi K. Inhibition by 1'-acetoxychavicol acetate of lipopolysaccharide- and interferon-gamma-induced nitric oxide production through suppression of inducible nitric oxide synthase gene expression in RAW264 cells. Carcinogenesis. 1998;19(6):1007-12. — PubMed PMID: 9667738
- Murakami A, Shigemori T, Ohigashi H. Zingiberaceous and citrus constituents, 1'-acetoxychavicol acetate, zerumbone, auraptene, and nobiletin, suppress lipopolysaccharide-induced cyclooxygenase-2 expression in RAW264.7 murine macrophages through different modes of action. Journal of Nutrition. 2005;135(12 Suppl):2987S-2992S. — PubMed PMID: 16317159
- Kojima-Yuasa A, Matsui-Yuasa I. Pharmacological effects of 1'-acetoxychavicol acetate, a major constituent in the rhizomes of Alpinia galanga and Alpinia conchigera. Journal of Medicinal Food. 2020;23(5):465-475. — PubMed PMID: 32069429
- Rampogu S, Gajula RG, Lee KW. A comprehensive review on chemotherapeutic potential of galangin. Biomedicine & Pharmacotherapy. 2021;141:111808. — PubMed PMID: 34175820
- Abubakar IB, Malami I, Yahaya Y, Sule SM. A review on the ethnomedicinal uses, phytochemistry and pharmacology of Alpinia officinarum Hance. Journal of Ethnopharmacology. 2018;224:45-62. — PubMed PMID: 29803568
- Altman RD, Marcussen KC. Effects of a ginger extract on knee pain in patients with osteoarthritis. Arthritis and Rheumatism. 2001;44(11):2531-8. A combined extract of ginger and greater galangal: 261 patients, 6 weeks, 63% versus 50% responders. — PubMed PMID: 11710709
- Chiranthanut N, Hanprasertpong N, Teekachunhatean S. Thai massage, and Thai herbal compress versus oral ibuprofen in symptomatic treatment of osteoarthritis of the knee: a randomized controlled trial. BioMed Research International. 2014;2014:490512. 60 patients, three weeks. — PubMed PMID: 25254207
- Dhippayom T, Kongkaew C, Chaiyakunapruk N, Dilokthornsakul P, Sruamsiri R, Saokaew S, Chuthaputti A. Clinical effects of Thai herbal compress: a systematic review and meta-analysis. Evidence-Based Complementary and Alternative Medicine. 2015;2015:942378. 13 studies, 778 patients. — PubMed PMID: 25861373
- Laosee O, Sritoomma N, Wamontree P, Rattanapan C, Sitthi-Amorn C. The effectiveness of traditional Thai massage versus massage with herbal compress among elderly patients with low back pain: a randomised controlled trial. Complementary Therapies in Medicine. 2020;48:102253. 140 patients; no added benefit from the compress. — PubMed PMID: 31987237
- Live search: Alpinia galanga, anti-inflammatory activity and carrageenan paw oedema — the rodent screening literature. — Search PubMed
- Live search: 1'-Acetoxychavicol acetate and NF-κB — the mechanistic core of this page.
- Live search: Thai herbal compress and knee osteoarthritis — the multi-herb, multi-modality trials discussed above.
- Live search: Galangin and cytochrome P450 inhibition — the basis for taking the interaction question seriously.
- Live search: Boswellia in osteoarthritis — randomised controlled trials — for contrast, a botanical that was tested. — Search PubMed
- Live search: Curcumin in knee osteoarthritis — randomised trials — the nearest relative with a clinical literature.
- Live search: Alpinia galanga clinical trials — run this one and count the results. That count is the honest measure of this page.
Safety and Disclaimer
Galangal as a culinary spice is safe and well tolerated in the quantities used in cooking. Concentrated extracts are largely unstudied, may interact with anticoagulants, antiplatelet drugs and medications cleared by cytochrome P450 enzymes, and have no safety data in pregnancy, breastfeeding or children. Their platelet effects in laboratory work are relevant before planned surgery. This article is educational and is not medical advice. Nothing here diagnoses or treats any condition, and no supplement replaces disease-modifying treatment for inflammatory arthritis or the assessment of joint pain that is persistent, swollen, or spreading.
Connections
- All Herbs
- Galangal Benefits Deep Dive — the hub for all four benefit articles.
- Galangal (Alpinia galanga) — botany, names, chemistry, forms, and cautions.
- Turmeric for Inflammation and Joint Health — the relative with real clinical data and a bioavailability problem.
- Ginger for Inflammation and Osteoarthritis — randomised knee osteoarthritis trials in the same plant family.
- Boswellia Benefits — a botanical anti-inflammatory that reached human trials.
- Black Pepper Benefits — piperine, and why absorption decides whether a mechanism matters.
- Quercetin — another flavonoid with a large in-vitro anti-inflammatory literature.
- Osteoarthritis — what actually helps a worn joint.
- Rheumatoid Arthritis — why delaying real treatment costs joints permanently.
- Arthritis — the umbrella page and how the types differ.
- Kencur (Kaempferia galanga) — the other "galangal", with its own anti-inflammatory chemistry.